Regulatory roles of copper metabolism and cuproptosis in human cancers

Copper is an essential micronutrient for human body and plays a vital role in various biological processes including cellular respiration and free radical detoxification. Generally, copper metabolism in the body is in a stable state, and there are specific mechanisms to regulate copper metabolism and maintain copper homeostasis. Dysregulation of copper metabolism may have a great connection with various types of diseases, such as Wilson disease causing copper overload and Menkes disease causing copper deficiency. Cancer presents high mortality rates in the world due to the unlimited proliferation potential, apoptosis escape and immune escape properties to induce organ failure. Copper is thought to have a great connection with cancer, such as elevated levels in cancer tissue and serum. Copper also affects tumor progression by affecting angiogenesis, metastasis and other processes. Notably, cuproptosis is a novel form of cell death that may provide novel targeting strategies for developing cancer therapy. Copper chelators and copper ionophores are two copper coordinating compounds for the treatment of cancer. This review will explore the relationship between copper metabolism and cancers, and clarify copper metabolism and cuproptosis for cancer targeted therapy.

[1]  Congcong Zhu,et al.  A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer , 2022, Frontiers in Immunology.

[2]  Yang Luo,et al.  Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma , 2022, Frontiers in Immunology.

[3]  X. Zu,et al.  Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma , 2022, Frontiers in Immunology.

[4]  Ninghan Feng,et al.  Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis , 2022, Frontiers in Pharmacology.

[5]  János Tóth,et al.  Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity , 2022, Frontiers in Immunology.

[6]  Z. Huang,et al.  Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer , 2022, Frontiers in Genetics.

[7]  Yong-chun Li,et al.  Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas , 2022, Frontiers in Immunology.

[8]  Yang Liu,et al.  Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer , 2022, Frontiers in Oncology.

[9]  Jianhao Zhang,et al.  Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker , 2022, Frontiers in Genetics.

[10]  Mei Li,et al.  Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer , 2022, Frontiers in Immunology.

[11]  Zhen Zhang,et al.  Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma , 2022, Frontiers in Immunology.

[12]  Jinhua Xu,et al.  Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma , 2022, Frontiers in Pharmacology.

[13]  Lingmin Xie,et al.  A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma , 2022, Genes.

[14]  R. He,et al.  Cuproptosis: copper-induced regulated cell death , 2022, Science China Life Sciences.

[15]  T. Golub,et al.  Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.

[16]  A. Seth,et al.  Association of heavy metals and trace elements in renal cell carcinoma: A case-controlled study. , 2021, Urologic oncology.

[17]  A. Rahimi,et al.  Association between trace elements in cancerous and non-cancerous tissues with the risk of breast cancers in western Iran , 2021, Environmental Science and Pollution Research.

[18]  L. Schomburg,et al.  Copper Isotopes and Copper to Zinc Ratio as Possible Biomarkers for Thyroid Cancer , 2021, Frontiers in Medicine.

[19]  D. Gu,et al.  Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear‐cell renal cell carcinoma , 2021, FEBS open bio.

[20]  F. Giorgi,et al.  Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics , 2021, ChemMedChem.

[21]  G. Ferns,et al.  Lysyl Oxidase Mechanisms to Mediate Gastrointestinal Cancer Progression , 2020, Gastrointestinal Tumors.

[22]  M. Petris,et al.  Copper metabolism as a unique vulnerability in cancer. , 2020, Biochimica et biophysica acta. Molecular cell research.

[23]  Yue Feng,et al.  Serum copper and zinc levels in breast cancer: A meta-analysis. , 2020, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[24]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[25]  M. Bhatt,et al.  Wilson disease. , 2020, Current opinion in neurology.

[26]  Ji Chen,et al.  The molecular mechanisms of copper metabolism and its roles in human diseases , 2020, Pflügers Archiv - European Journal of Physiology.

[27]  Duane D. Winkler,et al.  Copper Sources for Sod1 Activation , 2020, Antioxidants.

[28]  H. Adly,et al.  Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients , 2020, Current Urology.

[29]  S. Baldari,et al.  Current Biomedical Use of Copper Chelation Therapy , 2020, International journal of molecular sciences.

[30]  P. Wittung-Stafshede,et al.  Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration , 2020, Proceedings of the National Academy of Sciences.

[31]  P. Wittung-Stafshede,et al.  Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer , 2020, Breast Cancer.

[32]  L. Rossi,et al.  Copper homeostasis as target of both consolidated and innovative strategies of anti-tumor therapy. , 2019, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[33]  J. Collins,et al.  Animal Models of Normal and Disturbed Iron and Copper Metabolism. , 2019, The Journal of nutrition.

[34]  Ç. Yenisey,et al.  Serum Copper and Zinc Levels in Patients with Endometrial Cancer , 2019, Biological Trace Element Research.

[35]  K. Kazan,et al.  Ferroptosis: Yet Another Way to Die. , 2019, Trends in plant science.

[36]  Zhongguo Zhou,et al.  Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort , 2019, International journal of cancer.

[37]  T. Golub,et al.  Mitochondrial metabolism promotes adaptation to proteotoxic stress , 2019, Nature Chemical Biology.

[38]  K. Sui,et al.  Differential diagnosis of multielements in cancerous and non-cancerous esophageal tissues. , 2019, Talanta.

[39]  Shan Zhu,et al.  ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis , 2019, Proceedings of the National Academy of Sciences.

[40]  A. Pai Iron Oxide Nanoparticle Formulations for Supplementation. , 2019, Metal ions in life sciences.

[41]  M. Hou,et al.  Oxidative stress-modulating drugs have preferential anticancer effects - involving the regulation of apoptosis, DNA damage, endoplasmic reticulum stress, autophagy, metabolism, and migration. , 2019, Seminars in cancer biology.

[42]  R. Weinberg,et al.  New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer , 2018, Nature reviews. Molecular cell biology.

[43]  Xiaping Zhang,et al.  Association between serum copper levels and lung cancer risk: A meta-analysis , 2018, The Journal of international medical research.

[44]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[45]  J. Rybakowski,et al.  Wilson disease , 2018, Nature Reviews Disease Primers.

[46]  P. Siegel,et al.  Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations , 2018, Oncogene.

[47]  Min Zhang,et al.  Association between serum copper levels and cervical cancer risk: a meta-analysis , 2018, Bioscience reports.

[48]  D. Denoyer,et al.  Copper Complexes in Cancer Therapy. , 2018, Metal ions in life sciences.

[49]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[50]  M. Sohrabi,et al.  Trace Element and Heavy Metal Levels in Colorectal Cancer: Comparison Between Cancerous and Non-cancerous Tissues , 2018, Biological Trace Element Research.

[51]  M. Sohrabi,et al.  Trace Element and Heavy Metal Levels in Colorectal Cancer: Comparison Between Cancerous and Non-cancerous Tissues , 2017, Biological Trace Element Research.

[52]  P. Wittung-Stafshede,et al.  Roles of Copper-Binding Proteins in Breast Cancer , 2017, International journal of molecular sciences.

[53]  Jin‐Young Jang,et al.  Ceruloplasmin as a prognostic marker in patients with bile duct cancer , 2017, Oncotarget.

[54]  D. Richardson,et al.  Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics. , 2016, Metallomics : integrated biometal science.

[55]  J. Kładny,et al.  Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[56]  S. Shojaei,et al.  Serum Copper and Zinc Levels Among Iranian Colorectal Cancer Patients , 2016, Biological Trace Element Research.

[57]  Delphine Denoyer,et al.  Targeting copper in cancer therapy: 'Copper That Cancer'. , 2015, Metallomics : integrated biometal science.

[58]  T. Ganz,et al.  Ironing out Ferroportin. , 2015, Cell metabolism.

[59]  D. Thiele,et al.  Intestinal DMT1 is critical for iron absorption in the mouse but is not required for the absorption of copper or manganese. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[60]  Jie Cao,et al.  The Association Between Serum Levels of Selenium, Copper, and Magnesium with Thyroid Cancer: a Meta-analysis , 2015, Biological Trace Element Research.

[61]  V. Pavithra,et al.  Serum levels of metal ions in female patients with breast cancer. , 2015, Journal of clinical and diagnostic research : JCDR.

[62]  H. Mortazavi,et al.  Serum levels of ferritin, copper, and zinc in patients with oral cancer , 2014, Biomedical journal.

[63]  J. Seebacher,et al.  Memo Is a Copper-Dependent Redox Protein with an Essential Role in Migration and Metastasis , 2014, Science Signaling.

[64]  Anthony R White,et al.  Copper as a key regulator of cell signalling pathways , 2014, Expert Reviews in Molecular Medicine.

[65]  T. Lassmann,et al.  Ceruloplasmin Is a Novel Adipokine Which Is Overexpressed in Adipose Tissue of Obese Subjects and in Obesity-Associated Cancer Cells , 2014, PloS one.

[66]  S. Knapp,et al.  Copper is required for oncogenic BRAF signaling and tumorigenesis , 2013, Nature.

[67]  P. Devane,et al.  A CASE-CONTROLLED STUDY , 2014 .

[68]  D. Hanahan,et al.  Bioavailable copper modulates oxidative phosphorylation and growth of tumors , 2013, Proceedings of the National Academy of Sciences.

[69]  R. Mumper,et al.  D-penicillamine and other low molecular weight thiols: review of anticancer effects and related mechanisms. , 2013, Cancer letters.

[70]  T. Singh,et al.  Heavy and Trace Metals in Carcinoma of the Gallbladder , 2013, World Journal of Surgery.

[71]  Songming Huang,et al.  Zinc and Copper Levels in Bladder Cancer: A Systematic Review and Meta-Analysis , 2013, Biological Trace Element Research.

[72]  G. Kaiafa,et al.  Copper levels in patients with hematological malignancies. , 2012, European journal of internal medicine.

[73]  S. Nikolić-Mandić,et al.  Matrix Metalloproteinase-9 and the Cu/Zn Ratio as Ancillary Diagnostic Tools in Distinguishing Between the Classical and Follicular Variants of Papillary Thyroid Carcinoma , 2012, Biological Trace Element Research.

[74]  D. Thiele,et al.  A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling , 2012, Molecular and Cellular Biology.

[75]  F. Dammacco,et al.  Targeted therapies in cancer , 2018, Surgery (Oxford).

[76]  D. Skrajnowska,et al.  Effect of Cu supplementation on genomic instability in chemically-induced mammary carcinogenesis in the rat , 2011, Journal of Biomedical Science.

[77]  Y. Haupt,et al.  Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. , 2011, The Biochemical journal.

[78]  S. Kaler,et al.  ATP7A-related copper transport diseases—emerging concepts and future trends , 2011, Nature Reviews Neurology.

[79]  I. Khan,et al.  Abnormal Blood Levels of Trace Elements and Metals, DNA Damage, and Breast Cancer in the State of Kuwait , 2011, Biological Trace Element Research.

[80]  C. Marzano,et al.  Copper in diseases and treatments, and copper‐based anticancer strategies , 2009, Medicinal research reviews.

[81]  D. Winge,et al.  Copper metallochaperones. , 2010, Annual review of biochemistry.

[82]  A. Compston Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509. , 2009, Brain : a journal of neurology.

[83]  I. Sandoval,et al.  Molecular mechanisms of copper homeostasis. , 2009, Frontiers in bioscience.

[84]  Huiqi Xie,et al.  Role of copper in angiogenesis and its medicinal implications. , 2009, Current medicinal chemistry.

[85]  R. Mumper,et al.  Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. , 2009, Cancer treatment reviews.

[86]  A. Harris,et al.  The distribution of trace elements Ca, Fe, Cu and Zn and the determination of copper oxidation state in breast tumour tissue using μSRXRF and μXANES , 2008, Physics in medicine and biology.

[87]  M. Ushio-Fukai,et al.  Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell Proliferation* , 2008, Journal of Biological Chemistry.

[88]  D. Thiele,et al.  Mechanisms for copper acquisition, distribution and regulation. , 2008, Nature chemical biology.

[89]  M. Olivares,et al.  Ceruloplasmin, an Indicator of Copper Status , 2008, Biological Trace Element Research.

[90]  F. Schmidt Meta-Analysis , 2008 .

[91]  R. Vyas,et al.  A study of serum zinc, selenium and copper levels in carcinoma of esophagus patients , 2006, Indian Journal of Clinical Biochemistry.

[92]  P. Karplus,et al.  Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. , 2007, Journal of molecular biology.

[93]  Svetlana Lutsenko,et al.  Function and regulation of human copper-transporting ATPases. , 2007, Physiological reviews.

[94]  Bryan F. Shaw,et al.  Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. , 2007, Journal of the American Chemical Society.

[95]  F. Sarkar,et al.  Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. , 2007, Cancer research.

[96]  Diane J. Rodi,et al.  X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis , 2007, Proceedings of the National Academy of Sciences.

[97]  M. Yaman,et al.  Distribution of trace metal concentrations in paired cancerous and non-cancerous human stomach tissues. , 2007, World journal of gastroenterology.

[98]  Dar-Ren Chen,et al.  Serum and tissue trace elements in patients with breast cancer in Taiwan , 2002, Biological Trace Element Research.

[99]  E. Shoubridge,et al.  The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis. , 2007, Cell metabolism.

[100]  I. Bertini,et al.  Menkes disease , 2007, Cellular and Molecular Life Sciences.

[101]  Q Ping Dou,et al.  Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. , 2006, Cancer research.

[102]  M. Fleming,et al.  The Steap proteins are metalloreductases. , 2006, Blood.

[103]  M. Yaman,et al.  Comparison of trace element concentrations in cancerous and noncancerous human endometrial and ovary tissues , 2006, International Journal of Gynecologic Cancer.

[104]  S. Merajver,et al.  Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.

[105]  C. Keen,et al.  Copper, oxidative stress, and human health. , 2005, Molecular aspects of medicine.

[106]  J. Kaplan,et al.  Stable Plasma Membrane Levels of hCTR1 Mediate Cellular Copper Uptake* , 2005, Journal of Biological Chemistry.

[107]  D. Winge,et al.  Cox17 Is Functional When Tethered to the Mitochondrial Inner Membrane* , 2004, Journal of Biological Chemistry.

[108]  S. Lutsenko,et al.  A Mutation in the ATP7B Copper Transporter Causes Reduced Dopamine β-Hydroxylase and Norepinephrine in Mouse Adrenal , 2003, Neurochemical Research.

[109]  Chris Vulpe,et al.  Yeast, a model organism for iron and copper metabolism studies , 2003, Biometals.

[110]  Minh N. H. Nguyen,et al.  Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.

[111]  S. Merajver,et al.  Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma. , 2003, Molecular cancer therapeutics.

[112]  S. Merajver,et al.  Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model. , 2003, Archives of otolaryngology--head & neck surgery.

[113]  C. Keen,et al.  Developmental consequences of trace mineral deficiencies in rodents: acute and long-term effects. , 2003, The Journal of nutrition.

[114]  C. Kwik-Uribe,et al.  Copper-Deficient Rat Embryos Are Characterized by Low Superoxide Dismutase Activity and Elevated Superoxide Anions1 , 2003, Biology of reproduction.

[115]  P. Tengvall,et al.  IL-1α, IL-1β and TNF-α secretion during in vivo/ex vivo cellular interactions with titanium and copper , 2003 .

[116]  P. Tengvall,et al.  IL-1alpha, IL-1beta and TNF-alpha secretion during in vivo/ex vivo cellular interactions with titanium and copper. , 2003, Biomaterials.

[117]  M. Bonham,et al.  The immune system as a physiological indicator of marginal copper status? , 2002, The British journal of nutrition.

[118]  T Theophanides,et al.  Copper and carcinogenesis. , 2002, Critical reviews in oncology/hematology.

[119]  D. Thiele,et al.  Biochemical Characterization of the Human Copper Transporter Ctr1* , 2002, The Journal of Biological Chemistry.

[120]  J. Gitlin,et al.  Ceruloplasmin metabolism and function. , 2002, Annual review of nutrition.

[121]  S. Merajver,et al.  Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. , 2002, Neoplasia.

[122]  S. Merajver,et al.  Radiotherapy and antiangiogenic TM in lung cancer. , 2002, Neoplasia.

[123]  P. Gruss,et al.  The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[124]  K. Davies,et al.  Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.

[125]  J. Valentine,et al.  Yeast Lacking Cu-Zn Superoxide Dismutase Show Altered Iron Homeostasis , 2000, The Journal of Biological Chemistry.

[126]  D L Price,et al.  Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[127]  Brem Angiogenesis and Cancer Control: From Concept to Therapeutic Trial. , 1999, Cancer control : journal of the Moffitt Cancer Center.

[128]  W. Johnson,et al.  Copper Deprivation Potentiates Oxidative Stress in HL-60 Cell Mitochondria , 1999 .

[129]  P. Lee,et al.  Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. , 1997, The American journal of gastroenterology.

[130]  J. Morrow,et al.  Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[131]  S. Kannan,et al.  Serum levels of copper, zinc, iron and ceruplasmin in oral leukoplakia and squamous cell carcinoma. , 1997, Journal of experimental & clinical cancer research : CR.

[132]  F. Soncin,et al.  Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells. , 1997, Biochemical and biophysical research communications.

[133]  M. Linder,et al.  Copper biochemistry and molecular biology. , 1996, The American journal of clinical nutrition.

[134]  T. Tomizaki,et al.  Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 2.8 A , 1995, Science.

[135]  I. Bertini,et al.  A characterization of copper/zinc superoxide dismutase mutants at position 124. Zinc-deficient proteins. , 1991, European journal of biochemistry.

[136]  A. Hilliker,et al.  Phenotypic consequences of copper-zinc superoxide dismutase overexpression in Drosophila melanogaster. , 1990, Genome.

[137]  S. Naik,et al.  Role of ceruloplasmin in inflammation: increased serum ceruloplasmin levels during inflammatory conditions and its possible relationship with anti-inflammatory agents. , 1985, Pharmacological research communications.

[138]  I. Fridovich Superoxide radical: an endogenous toxicant. , 1983, Annual review of pharmacology and toxicology.

[139]  O. Rennert,et al.  The role of copper in iron metabolism. , 1980, Annals of clinical and laboratory science.

[140]  E. Underwood,et al.  Changes in activity of the Cu-Zn superoxide dismutase enzyme in tissues of the rat with changes in dietary copper. , 1979, The Journal of nutrition.

[141]  R. C. Siegel Lysyl oxidase. , 1979, International review of connective tissue research.

[142]  M. Shifrine,et al.  Hypothesis for the mechanism of elevated serum copper in cancer patients. , 1978, Oncology.

[143]  J. Menkes KINKY HAIR DISEASE , 1972, Pediatrics.